Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:07:21.731Z.
Calculation as of: 2026-10-06T18:07:21.731Z.
Quote observation: 2026-10-06T18:05:21.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a99f3f088f54f9f9c0225e5104dac3e52b54f392bb47ad8d1f9af79329b73e7d
EARNINGS YIELD
N/A
Market Cap
$4.39B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.42B
Earnings Yield
7.87%
TTM Avg
5.11%
3Y Avg
3.07%
5Y Avg
3.43%
Market Cap
$4.44B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.03B
Earnings Yield
N/A
TTM Avg
6.68%
3Y Avg
4.79%
5Y Avg
4.79%
Market Cap
$4.66B
Earnings Yield
4.28%
TTM Avg
4.92%
3Y Avg
4.57%
5Y Avg
3.88%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | $4.27B | N/A | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.39B | N/A | N/A | N/A | N/A |
| LivaNova PLC (LIVN)vs › | $4.14B | 4.50% | 3.24% | 1.64% | 1.64% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.42B | 7.87% | 5.11% | 3.07% | 3.43% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.44B | N/A | N/A | N/A | N/A |
| AbCellera Biologics Inc. (ABCL)vs › | $4.03B | N/A | 6.68% | 4.79% | 4.79% |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.00B | N/A | N/A | N/A | N/A |
| ICU Medical, Inc. (ICUI)vs › | $3.96B | 0.74% | 0.70% | 0.70% | 1.21% |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | 4.28% | 4.92% | 4.57% | 3.88% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 1.08% | 0.64% | 0.64% | 0.64% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
